Physician profile
Thomas J Kirn
NPI 1457418444
$12,606.70
in general payments reported to CMS, 2019-2025
4 companies · $7,792 in 2025
The $7,792 reported for 2025 was more than what 84% of Clinical Pathology providers received nationally (typical 2025 total: $116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $500 · 2022: $3,825 · 2024: $490 · 2025: $7,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $7,473 · Consulting Fee: $490 · Travel and Lodging: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $7,472.50 |
| Consulting Fee | $490.00 |
| Travel and Lodging | $319.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $8,281.70 | 2024-2025 | Bd Max System, Bd Max Instrument |
| Roche Diagnostics Corporation | $2,825.00 | 2022 | |
| Opgen, INC. | $1,000.00 | 2022 | |
| Accelerate Diagnostics INC. | $500.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kirn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.